Please use this identifier to cite or link to this item: https://apo.ansto.gov.au/dspace/handle/10238/11294
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZhang, B-
dc.contributor.authorPascali, G-
dc.contributor.authorWyatt, NA-
dc.contributor.authorMatesic, L-
dc.contributor.authorKlenner, MA-
dc.contributor.authorSia, TR-
dc.contributor.authorGuastella, AJ-
dc.contributor.authorMassi, M-
dc.contributor.authorRobinson, AJ-
dc.contributor.authorFraser, BH-
dc.date.accessioned2021-08-10T02:19:02Z-
dc.date.available2021-08-10T02:19:02Z-
dc.date.issued2018-06-20-
dc.identifier.citationZhang, B., Pascali, G., Wyatt, N., Matesic, L., Klenner, M. A., Sia, T. R., Guastella, A. J., Massi, M., Robinson, A. J. & Fraser, B. H. (2018). Synthesis, bioconjugation and stability studies of [18F]ethenesulfonyl fluoride. 61(11), 847-856. doi:10.1002/jlcr.3667en_US
dc.identifier.issn1099-1344-
dc.identifier.urihttps://doi.org/10.1002/jlcr.3667en_US
dc.identifier.urihttps://apo.ansto.gov.au/dspace/handle/10238/11294-
dc.description.abstractFluorine-18 labelled prosthetic groups (PGs) are often necessary for radiolabelling sensitive biological molecules such as peptides and proteins. Several shortcomings, however, often diminish the final yield of radiotracer. In an attempt to provide higher yielding and operationally efficient tools for radiolabelling biological molecules, we describe herein the first radiochemical synthesis of [18F]ethenesulfonyl fluoride ([18F]ESF) and its Michael conjugation with amino acids and proteins. The synthesis of [18F]ESF was optimised using a microfluidic reactor under both carrier-added (c.a.) and no-carrier-added (n.c.a.) conditions, affording, in a straightforward procedure, 30-50% radiochemical yield (RCY) for c.a. [18F]ESF and 60-70% RCY for n.c.a. [18F]ESF. The conjugation reactions were performed at room temperature using 10 mg/mL precursor in aqueous/organic solvent mixtures for 15 min. The radiochemical stability of the final conjugates was evaluated in injectable formulation and rat serum, and resulted strongly substrate dependent and generally poor in rat serum. Therefore, in this work we have optimised a straightforward synthesis of [18F]ESF and its Michael conjugation with model compounds, without requiring chromatographic purification. However, given the general low stability of the final products, further studies will be required for improving conjugate stability, before assessing the use of this PG for PET imaging. © 2018 John Wiley & Sons, Inc.en_US
dc.language.isoenen_US
dc.publisherJohn Wiley & Sons, Incen_US
dc.subjectFluorine 18en_US
dc.subjectLabellingen_US
dc.subjectPeptidesen_US
dc.subjectProteinsen_US
dc.subjectMoleculesen_US
dc.subjectYieldsen_US
dc.subjectTracer techniquesen_US
dc.subjectAmino acidsen_US
dc.subjectCarriersen_US
dc.subjectPositron computed tomographyen_US
dc.titleSynthesis, bioconjugation and stability studies of [18F]ethenesulfonyl fluorideen_US
dc.typeJournal Articleen_US
dc.date.statistics2021-08-10-
Appears in Collections:Journal Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.